AN 415 (Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base))

Pill imprint AN 415 has been identified as Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 8 mg (base) / 2 mg (base).

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 8 mg (base) / 2 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual)

Imprint:

AN 415

Strength:

8 mg (base) / 2 mg (base)

Color:

Orange

Shape:

Round

Availability:

Prescription only

Drug Class:

Narcotic analgesic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

3 - Moderate abuse potential

Manufacturer:

Amneal Pharmaceuticals

National Drug Code (NDC):

65162-0415

Inactive Ingredients:

acesulfame potassium
citric acid anhydrous
FD&C Yellow No. 6
lactose monohydrate
magnesium stearate
mannitol
povidone
sodium citrate
corn starch

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
42291-0175	AvKare, Inc.
00406-1924	Mallinckrodt Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.